V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014006 | 160012450 | 1.6 | 83.4 | Palliative (P) | 2020-11-19 | 2020-12-04 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 101695620 |
| 160014007 | 160012451 | 1.52 | 83.5 | null | null | 2018-02-25 | Bevacizumab | 02 | null | BEVACIZUMAB | 100541748 |
| 160014009 | 160012452 | 1.63 | 92 | null | 2017-04-07 | 2017-05-01 | Bevacizumab 7.5mg/kg | 02 | null | CISPLATIN + PEMETREXED | 100228429 |
| 160014011 | 160012453 | 1.74 | 74 | Palliative (P) | 2018-08-13 | 2019-03-26 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100783308 |
| 160014015 | 160012454 | 1.65 | 132.4 | 03 | 2020-03-19 | 2020-04-03 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100886435 |
| 160014017 | 160012455 | 1.81 | 72.8 | null | 2020-12-29 | 2021-01-16 | DOCETAXEL + GEMCITABINE | 2 | null | DOCETAXEL + GEMCITABINE | 101430960 |
| 160014019 | 160012456 | 1.79 | 96.8 | null | 2016-05-16 | 2017-03-01 | Bevacizumab 7.5mg/kg | null | null | CARBOPLATIN + PACLITAXEL | 101111338 |
| 160014020 | 160012457 | 1.51 | 56 | null | 2019-01-08 | 2019-01-10 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101493979 |
| 160014021 | 160012458 | 1.7 | 61.1 | Palliative (P) | 2018-10-22 | 2018-11-05 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100186641 |
| 160014032 | 160012459 | 1.6 | 90 | null | 2019-07-21 | 2019-07-26 | Bevacizumab | 02 | null | DOCETAXEL + GEMCITABINE | 101215761 |
| 160014033 | 160012460 | 1.53 | null | Palliative (P) | 2018-05-20 | 2018-06-15 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100836716 |
| 160014034 | 160012461 | 1.46 | 103.4 | null | 2017-09-23 | 2020-01-06 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101096506 |
| 160014037 | 160012462 | 1.77 | 65.8 | Adjuvant (A) | 2019-05-09 | 2019-05-09 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100243025 |
| 160014038 | 160012463 | 1.56 | 82.9 | Neo-adjuvant (N) | 2019-01-30 | 2019-02-27 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 101230305 |
| 160014040 | 160012464 | 1.51 | 63.2 | Palliative (P) | 2018-09-01 | 2018-09-03 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101320546 |
| 160014051 | 160012465 | 1.53 | 70.9 | Palliative (P) | 2018-01-04 | 2018-01-04 | Bevacizumab 15mg/kg | 02 | N | PACLITAXEL | 100072836 |
| 160014054 | 160012466 | 1.61 | 82.15 | 03 | 2017-11-11 | 2017-11-28 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101469650 |
| 160014059 | 160012467 | 1.79 | 53.3 | Palliative (P) | 2017-06-27 | 2017-06-27 | Carboplatin + Liposomal Doxorubicin | 02 | N | LIPOSOMAL DOXORUBICIN | 101675988 |
| 160014061 | 160012468 | 1.68 | 87.4 | Palliative (P) | 2016-10-25 | 2016-11-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100986507 |
| 160014062 | 160012469 | 1.75 | 55.4 | Palliative (P) | 2016-08-12 | 2016-09-03 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100004977 |
| 160014063 | 160012470 | 1.49 | 73.6 | Palliative (P) | 2019-01-15 | 2019-01-15 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101497138 |
| 160014064 | 160012471 | 1.79 | 72.2 | Palliative (P) | 2018-08-11 | 2018-09-15 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 101296044 |
| 160014066 | 160012472 | 1.7 | 53.9 | Palliative (P) | 2018-11-28 | 2018-12-11 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 101246980 |
| 160014067 | 160012473 | 1.83 | 76.2 | null | 2019-08-09 | 2019-08-12 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + PACLITAXEL | 101529819 |
| 160014070 | 160012474 | 1.89 | 72.1 | null | 2020-07-30 | 2021-02-21 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 101759999 |
| 160014071 | 160012475 | 1.74 | 64.3 | Palliative (P) | 2016-06-01 | 2016-06-26 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 100428180 |
| 160014077 | 160012476 | 1.69 | null | Palliative (P) | 2017-10-12 | 2017-10-12 | Liposomal Doxorubicin 50mg/m2 | N | N | LIPOSOMAL DOXORUBICIN | 100172350 |
| 160014082 | 160012477 | 1.66 | 69.6 | null | 2019-10-14 | 2020-02-12 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 101162962 |
| 160014083 | 160012478 | 1.73 | 62 | Adjuvant (A) | 2018-06-28 | 2018-07-27 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101336719 |
| 160014087 | 160012479 | 1.77 | 49.2 | null | 2018-05-27 | 2018-06-05 | Bevacizumab | 02 | null | BEVACIZUMAB | 101088330 |
| 160014088 | 160012480 | 1.54 | 47.7 | Palliative (P) | 2016-12-07 | 2017-01-02 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 100959305 |
| 160014089 | 160012481 | 1.7 | 50.4 | Palliative (P) | 2020-01-15 | 2020-01-29 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100967448 |
| 160014092 | 160012482 | 1.73 | 99.5 | Palliative (P) | 2022-03-01 | 2022-03-16 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100272688 |
| 160014093 | 160012483 | 1.64 | 85 | null | 2020-03-21 | 2020-04-02 | Bevacizumab | 02 | null | PACLITAXEL | 101561661 |
| 160014094 | 160012484 | 1.83 | 123 | Palliative (P) | 2018-07-06 | 2019-01-03 | Carboplatin + Liposomal Doxorubicin | 2 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100133327 |
| 160014097 | 160012485 | 1.73 | 63.4 | Palliative (P) | 2018-02-16 | 2018-02-20 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 101371957 |
| 160014098 | 160012486 | 1.73 | 88.4 | null | 2019-07-07 | 2019-07-07 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 100495599 |
| 160014100 | 160012487 | 1.67 | 110.2 | Palliative (P) | 2018-12-31 | 2019-01-16 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 100775582 |
| 160014105 | 160012488 | 1.78 | 66.8 | null | 2015-01-04 | 2016-11-21 | Bevacizumab 15mg/kg | 01 | N | PACLITAXEL | 100081806 |
| 160014108 | 160012489 | 1.61 | 64 | Palliative (P) | 2019-06-04 | 2019-11-05 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100839556 |
| 160014109 | 160012490 | 1.54 | 104.6 | Adjuvant (A) | 2016-06-03 | 2016-06-18 | Bevacizumab | 02 | N | BEVACIZUMAB | 100238749 |
| 160014110 | 160012491 | 1.5 | 80.7 | null | 2019-12-28 | 2020-01-16 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101054840 |
| 160014117 | 160012492 | 1.78 | 48 | Curative (C) | 2018-05-18 | 2018-05-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101109217 |
| 160014119 | 160012493 | 0.02 | null | null | 2017-03-06 | 2017-03-09 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101716450 |
| 160014122 | 160012494 | 1.61 | 50 | Palliative (P) | 2018-01-13 | 2018-02-08 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100791141 |
| 160014125 | 160012495 | 1.77 | 70.6 | Palliative (P) | 2018-10-04 | 2018-10-23 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101613467 |
| 160014133 | 160012496 | 1.95 | 70.6 | Neo-adjuvant (N) | 2017-10-18 | 2017-10-25 | Bevacizumab 7.5mg/kg | 02 | null | DOXORUBICIN + OLARATUMAB | 100503299 |
| 160014138 | 160012497 | 1.73 | 85 | null | 2016-11-10 | 2016-12-03 | Bevacizumab | 02 | null | PACLITAXEL | 100667969 |
| 160014142 | 160012498 | 1.78 | 65 | null | 2019-09-25 | 2019-10-02 | Bevacizumab | 02 | null | PACLITAXEL | 100891848 |
| 160014143 | 160012499 | 1.7 | 49.2 | null | 2022-04-13 | 2022-04-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100218003 |